HeadlineShine

Merck tops quarterly estimates, hikes profit outlook as new form of Keytruda shows strength

CNBCMerck tops quarterly estimates, hikes profit outlook as new form of Keytruda shows strength
Image: CNBC

Merck's immunotherapy Keytruda, including a newer injectable form of the drug, showed stronger-than-expected sales.

Summary from CNBC

Read the full story on CNBC
React

Trending now

More business

See all →

Top stories in the United States

See all →